:: دوره 8، شماره 4 - ( 10-1398 ) ::
جلد 8 شماره 4 صفحات 22-16 برگشت به فهرست نسخه ها
Promising Role of CD200 Expression in Diagnosis and Prognosis of Chronic Lymphocytic Leukemia: A Review
چکیده:   (4058 مشاهده)
One of the most common leukemia in the world is chronic lymphocytic leukemia (CLL). CLL, as an incurable malignant disorder of B-lymphocytes. CD200, formerly known as OX-2, is a type I glycoprotein that is expressed on a variety of cell types. CD200 plays a vital role in the modulation of the immune system and is upregulated on the surface of numerous tumors, including chronic lymphocytic leukemia. In several studies, it is noted that CD200 was upregulated 1.6- to 5.4-fold in B cells from all patients with B-CLL and may suggest that CD200 upregulation is an early event in the B-CLL disease process. It might conclude that CD200 blocking therapy may be beneficial, and several studies have proven this. We can conclude that CD200 is an excellent prognostic factor that expresses in most CLL patients, and antiCD200 therapeutic interventions can be useful. This literature review article was conducted with the purpose of role of CD200 Expression in the Diagnosis of Chronic Lymphocytic Leukemia.
     
نوع مطالعه: پژوهشي | موضوع مقاله: عمومى


XML     Print



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 8، شماره 4 - ( 10-1398 ) برگشت به فهرست نسخه ها